Found: 133
Select item for more details and to access through your institution.
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period.
- Published in:
- BMC Infectious Diseases, 2024, p. 1, doi. 10.1186/s12879-024-09108-3
- By:
- Publication type:
- Article
Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2024, v. 13, n. 1, p. 100, doi. 10.1093/jpids/piad109
- By:
- Publication type:
- Article
Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network.
- Published in:
- Influenza & Other Respiratory Viruses, 2023, v. 17, n. 5, p. 1, doi. 10.1111/irv.13143
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 8, p. 1358, doi. 10.1093/cid/ciac941
- By:
- Publication type:
- Article
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022.
- Published in:
- Influenza & Other Respiratory Viruses, 2023, v. 17, n. 3, p. 1, doi. 10.1111/irv.13104
- By:
- Publication type:
- Article
Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness -- Wisconsin, October 2022-February 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 8, p. 201, doi. 10.15585/mmwr.mm7208a1
- By:
- Publication type:
- Article
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data.
- Published in:
- American Journal of Epidemiology, 2023, v. 192, n. 2, p. 205, doi. 10.1093/aje/kwac170
- By:
- Publication type:
- Article
Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 6, p. 975, doi. 10.1111/irv.13029
- By:
- Publication type:
- Article
Human papillomavirus vaccine beliefs and practice characteristics in rural and urban adolescent care providers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 4, p. 607, doi. 10.1111/irv.12970
- By:
- Publication type:
- Article
Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 4, p. 673, doi. 10.1111/irv.12973
- By:
- Publication type:
- Article
Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 3, p. 562, doi. 10.1111/irv.12933
- By:
- Publication type:
- Article
Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Role of Age in the Spread of Influenza, 2011–2019: Data From the US Influenza Vaccine Effectiveness Network.
- Published in:
- American Journal of Epidemiology, 2022, v. 191, n. 3, p. 465, doi. 10.1093/aje/kwab205
- By:
- Publication type:
- Article
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized Open-Label Trial.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. 1973, doi. 10.1093/cid/ciab566
- By:
- Publication type:
- Article
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States—2019–2020.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4244, doi. 10.1093/cid/ciaa1884
- By:
- Publication type:
- Article
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 6, p. 697, doi. 10.1111/irv.12880
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. 386, doi. 10.1093/cid/ciaa407
- By:
- Publication type:
- Article
Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. 497, doi. 10.1093/cid/ciaa706
- By:
- Publication type:
- Article
Impact of Immune Priming, Vaccination, and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 7, p. 1147, doi. 10.1093/cid/ciaa102
- By:
- Publication type:
- Article
Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection -- Tennessee and Wisconsin, April--September 2020.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 69, n. 51/52, p. 1634
- By:
- Publication type:
- Article
Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa576
- By:
- Publication type:
- Article
Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2020, v. 69, n. 44, p. 1631, doi. 10.15585/mmwr. mm6944e1
- By:
- Publication type:
- Article
Prediction of serious RSV‐related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons.
- Published in:
- Influenza & Other Respiratory Viruses, 2020, v. 14, n. 5, p. 479, doi. 10.1111/irv.12751
- By:
- Publication type:
- Article
Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness.
- Published in:
- JAMA Pediatrics, 2020, v. 174, n. 7, p. 705, doi. 10.1001/jamapediatrics.2020.0372
- By:
- Publication type:
- Article
Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013–2014 Through 2015–2016.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 2, p. 173, doi. 10.1093/jpids/piz001
- By:
- Publication type:
- Article
Serious outcomes of medically attended, laboratory‐confirmed influenza illness among school‐aged children with and without asthma, 2007‐2018.
- Published in:
- Influenza & Other Respiratory Viruses, 2020, v. 14, n. 2, p. 173, doi. 10.1111/irv.12710
- By:
- Publication type:
- Article
Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2020, v. 69, n. 7, p. 177, doi. 10.15585/mmwr.mm6907a1
- By:
- Publication type:
- Article
Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 11, p. 1845, doi. 10.1093/cid/ciz075
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness: Defining the H3N2 Problem.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 10, p. 1817, doi. 10.1093/cid/ciz411
- By:
- Publication type:
- Article
900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S27, doi. 10.1093/ofid/ofz359.059
- By:
- Publication type:
- Article
2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S962, doi. 10.1093/ofid/ofz360.2412
- By:
- Publication type:
- Article
2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S973, doi. 10.1093/ofid/ofz360.2437
- By:
- Publication type:
- Article
2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S974, doi. 10.1093/ofid/ofz360.2440
- By:
- Publication type:
- Article
2767. Variation in Incidence of Pediatric Herpes Zoster by First- and Second-Dose Varicella Vaccine Formulations.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S975, doi. 10.1093/ofid/ofz360.2444
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 11, p. 1798, doi. 10.1093/cid/ciy775
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011–2017.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1616, doi. 10.1093/cid/ciy780
- By:
- Publication type:
- Article
Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011‐12—2015‐16.
- Published in:
- Influenza & Other Respiratory Viruses, 2019, v. 13, n. 2, p. 133, doi. 10.1111/irv.12616
- By:
- Publication type:
- Article
Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 12, p. N.PAG, doi. 10.1093/ofid/ofy316
- By:
- Publication type:
- Article
Validation of self‐reported influenza vaccination in the current and prior season.
- Published in:
- Influenza & Other Respiratory Viruses, 2018, v. 12, n. 6, p. 808, doi. 10.1111/irv.12593
- By:
- Publication type:
- Article
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Determinants of human papillomavirus vaccine attitudes: an interview of Wisconsin parents.
- Published in:
- 2018
- By:
- Publication type:
- journal article
2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 5, p. 665, doi. 10.1093/cid/cix869
- By:
- Publication type:
- Article
Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.
- Published in:
- Journal of Medical Virology, 2018, v. 90, n. 3, p. 436, doi. 10.1002/jmv.24975
- By:
- Publication type:
- Article
Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.
- Published in:
- 2018
- By:
- Publication type:
- journal article